Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 44,642 | 47,538 | 21,252 | 1,535 | 0 |
| Cost of Goods | 3,764 | 3,184 | 1,259 | 86 | N/A |
| Gross Profit | 40,878 | 44,354 | 19,993 | 1,449 | N/A |
| Operating Expenses | 47,924 | 41,970 | 33,023 | 24,124 | 17,223 |
| Operating Income | -6,282 | 2,568 | -12,771 | -22,589 | -17,223 |
| Interest Expense | 2,080 | 4,069 | 3,394 | 978 | 126 |
| Other Income | -1,273 | 1,430 | 120 | -138 | 3 |
| Pre-tax Income | -9,635 | -71 | -16,045 | -23,705 | -17,346 |
| Income Tax | 106 | 365 | N/A | N/A | N/A |
| Net Income Continuous | -9,741 | -436 | -16,045 | -23,705 | -17,346 |
| Net Income | $-9,741 | $-436 | $-16,045 | $-23,705 | $-17,346 |
| EPS Basic Total Ops | -0.34 | -0.02 | -0.60 | -0.90 | -0.67 |
| EPS Basic Continuous Ops | -0.34 | -0.02 | -0.60 | -0.90 | -0.67 |
| EPS Diluted Total Ops | -0.34 | -0.02 | -0.60 | -0.90 | -0.67 |
| EPS Diluted Continuous Ops | -0.34 | -0.02 | -0.60 | -0.90 | -0.67 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.00 | -0.60 | -0.90 | -0.67 |
| EBITDA(a) | $-6,114 | $3,527 | $-12,484 | $-22,440 | $-17,207 |